MarketsStocksEMCURE
EM

Emcure Pharmaceuticals Ltd

NSE: EMCUREBSE: 544210Healthcare
Download Research Report7-page PDF
1,720.00
-2.09%
NSE · auto-updates while market open
Prev Close
₹1,327.40
Day High
₹1,792.00
Day Low
₹1,711.60
Mkt Cap
₹32,071 Cr
P / E
34.1
P / B
6.5
ROE
20.0%
52W High
₹1,830.00
52W Low
₹1,228.90
Key Metrics
Market Cap
₹32,071 Cr
P / E
34.08
P / B
6.48
EV / EBITDA
18.75
ROCE
25.3%
ROE
20.0%
Debt / Equity
0.24
Book Value
₹261.09
EPS
₹48.77
Div Yield
0.2%
Face Value
₹10
Promoter Holding
77.9%
Revenue · ₹ Cr
7.9k
FY25
9.2k
FY26
Net Profit · ₹ Cr
707
FY25
941
FY26
EPS · ₹ per share
₹36.4
FY25
₹48.8
FY26
P / E Ratio · price ÷ TTM EPS
2429344056260-4Apr 25Aug 25Jan 26Jun 26
P/E 35.3×Median 33.4×TTM EPS
Q1 2026 snapshot
Sales
₹2.47K Cr
Operating profit
-
OPM
-
Net profit
₹244 Cr
EPS
₹12.84
Scorecard · 7 axes
Quality
Strong
77/100
Valuation
Avg
34.1×
Growth
Avg
+9.8%
Profitability
Strong
22.6%
Performance
Good
+31.9%
Entry Point
Weak
94%
Red Flags
Strong
0 flags
Shareholding Pattern
77.9%Promoter
Promoter77.9%
FII3.4%
DII6.1%
Public12.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue1,962.632,120.72,104.232,272.952,365.332,473.7
Net Profit156.091197.237214.793251.37231.37243.736
NPM %8.0%9.3%10.2%11.1%9.8%9.9%
AlertPre-trade